The appetite-suppressing drugs decrease a person's intake of food and nutrients, which can impact bone health and lead to ...

Recent studies show GLP-1s tied higher osteoporosis risk, with variations by diabetes status and weight changes in large patient datasets.

About 4% of GLP-1 users developed osteoporosis, compared with a little over 3% of nonusers — an increased risk of about 30%. A related condition, osteomalacia, which involves the softening of the ...

CLEVELAND, Ohio — A new bone strength testing technology developed at Ohio University shows promise in identifying women at risk for fractures more accurately than the current standard screening ...

A bone-crushing side effect? The benefits of GLP-1 drugs like Ozempic are myriad, from weight loss to improved cardiovascular health to potentially preventing dementia, lowering the risk of depression ...

A new research study has shed light on potential side effects of GLP-1 drugs, including Wegovy and Ozempic. According to a ...

New research suggests popular GLP-1 weight loss drugs like Ozempic, Wegovy, and Mounjaro may raise the risk of osteoporosis and gout. A large five-year study found slightly higher rates of bone ...

GLP-1 weight loss drugs could increase risk of osteoporosis and gout, new research finds - ...

While women have it more often, it’s just as dangerous for men.

An AKI episode is an independent risk factor for future bone fractures and warrants monitoring. Bone fracture may be among the adverse outcomes of acute kidney injury (AKI), investigators suggest. In ...

Many people don’t think about bone health until later in life, when issues like osteopenia (low bone density), osteoporosis ...